Plasminogen activator inhibitor-1 promotes synaptogenesis and protects against Aβ1-42-induced neurotoxicity in primary cultured hippocampal neurons

International Journal of Neuroscience

Volumn 123, Issue 1, 2012, Pages 42-49

  Cho, Harim ^a   Joo, Yuyoung ^a   Kim, Seonghan ^b   Woo, Ran Sook ^c   Lee, Sang Hyung ^a,d,e   Kim, Hye Sun ^a,d  

^a Seoul National University   (South Korea)

^b Inje University   (South Korea)

^c Eulji University   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

A oligomer; Neuronal survival; Plasminogen activator inhibitor 1; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; NERVE CELL ADHESION MOLECULE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SYNAPTOGENESIS; UPREGULATION;

EID: 84871393485     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.724127     Document Type: Article

References (36)

1. Gravanis I, Tsirka SE. Tissue plasminogen activator and glial function. Glia. 2005;49(2):177-83.
2. Hultman K, Blomstrand F, Nilsson M, Wilhelmsson U, Malmgren K, Pekny M, Kousted T, Jern C, Tjärnlund-Wolf A. Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: response to injury-related factors. J Neurosci Res. 2010;88(11):2441-9.
3. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neu-ronal damage after focal cerebral ischemia in wild-type and tPA-defcient mice. Nat Med. 1998;4(2):228-31.
4. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001;7(1):59-64.
5. Docagne F, Nicole O, Gabriel C, Fernandez-Monreal M, Lesne S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. Smad3-depedent induction of plas-minogen activator inhibitor-1 in astrocytes mediates neuropro-tective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci. 2002;21(4): 634-44.
6. Kruithof EK. Regulation of plasminogen activator inhibitor type 1 gene expression by infammatory mediators and statins. Thromb Haemost. 2008;100(6):969-75.
7. Nagamine Y. Transcriptional regulation of the plasminogen activator inhibitor type 1\with an emphasis on negative regulation. Thromb Haemost. 2008;100(6):1007-13.
8. Booth GE, Kinrade EF, hidalgo A. Glia maintain follower neuron survival during Drosophila CNS development. Development. 2000;127:237-44.
9. Quincozes-Santos A, Gottfried C. Resveratrol modulates as-troglial functions: neuroprotective hypothesis. Ann N Y Acad Sci. 2011;1215:72-8.
10. Pfrieger FW, Barres BA. Synaptic effcacy enhanced by glial cells in vitro. Science. 1997;277:1684-7.
11. Guizzetti M, Moore NH, Giordano G, Costa LG. Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem. 2008;183:31884-97.
12. Galliciotti G, Sonderergger P. Neuroserpin. Front Biosci. 2006;11:33-45.
13. Kinghorn KJ, Crowther DC, Sharp LK, Nerelius C, Davis RL, Chang HT, Green C, Gubb DC, Johansson J, Lomas DA. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J Biol Chem. 2006;281(39):29268-77.
14. Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs. 2009;14:67-84.
15. Clare R, King VG, Wirenfeldt M, Vinters HV. Synapse loss in dementias. J Neurosci Res. 2010;88(10):2083-90
16. Jang DJ, Park SW, Kaang BK. The role of lipid binding for the targeting of synaptic proteins into synaptic vesicles. BMB Rep. 2009;42(1):1-5.
17. Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR. Comparative evaluation of synaptophysin-based methods for quantifcation of synapses. J Neurocytol. 1996;25(12):821-8.
18. Ujike H, Takaki M, Kodama M, Kuroda S. Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann N Y Acad Sci. 2002;965:55-67.
19. Hunt CA, Schenker LJ, Kennedy MB, PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses. J Neurosci. 1996;16 (4): 1380-8.
20. Gascon E, Vutskits L, Kiss JZ. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev. 2007;56:101-18.
21. Checler F, Suh YH. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev. 2000;54(3):469-525.
22. Chotard C, Salecher I. Neurons and glia: team players in axon guidance. Trends Neurosci. 2004;27:655-61.
23. Elmariah SB, Hughes EG, Oh EJ, Balice-Gordon RJ. Neu-rotrophin signaling among neurons and glia during formation of tripartite synapses. Neuron Glia Biol. 2005;1: 1-11.
24. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919-37.
25. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neu-rosci. 2001;2:24-32.
26. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004;5:771-81.
27. Han K, Kim E. Synaptic adhesion molecules and PSD-95. Prog Neurobiol. 2008;84:263-83.
28. Bastrikova N, Gardner GA, Reece JM, Jeromin A, Dudek SM. Synapse elimination accompanies functional plasticity in hippocampal neurons. Proc Natl Acad Sci USA. 2008;105(8):3123-7.
29. Kawahara M, Ohtsuka I, Yokoyama S, Kato-Negishi M, Sadakane Y. Membrane incorporation, channel formation, and disruption of calcium homeostasis by Alzheimer's β-amyloid protein. Int J Alzheimers Dis. 2011;2011:304583.
30. Axelsen PH, Komatsu H, Murray IV. Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease. Physiology (Bethesda). 2011;26(1):54-69.
31. Costa RO, Ferreiro E, Martins I, Santana I, Cardoso SM, Oliveira CR, Pereira CM. Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions. Neurobiol Aging. 2012;33(4):824.e5-16.
32. Wilcox KC, Lacor PN, Pitt J, Klein WL. Aβ oligomer-induced synapse degeneration in Alzheimer's disease. Cell Mol Neuro-biol. 2011;31(6):939-48.
33. Tran TT, Srivareerat M, Alhaider IA, Alkadhi KA. Chronic psy-chosocial stress enhances long-term depression in a subthrehold amyloid-beta rat model of Alzheimer's disease. J Neurochem. 2011;119:408-16.
34. O'Leary OF, Wu X, Castren E. Chronic fuoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signaling. Psychoneu-roendocrinology. 2009;34:367-81.
35. Chen X, Vinade L, Leapman RD, Petersen JD, Nakagawa T, Phillips TM, Sheng M, Reese TS. Mass of the postsynaptic density and enumeration of three key molecules. Proc Natl Acad Sci USA. 2005;102:11551-6.
36. Bukhari N, Torres L, Robinson JK, Tsirka SE. Axonal re-growth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system. J Neurosci. 2011;31(42):14931-43.